Bibliographic Details
Title: |
Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36. |
Authors: |
Ettrup, Anders, da Cunha-Bang, Sophie, McMahon, Brenda, Lehel, Szabolcs, Dyssegaard, Agnete, Skibsted, Anine W, Jørgensen, Louise M, Hansen, Martin, Baandrup, Anders O, Bache, Søren, Svarer, Claus, Kristensen, Jesper L, Gillings, Nic, Madsen, Jacob, Knudsen, Gitte M |
Source: |
Journal of Cerebral Blood Flow & Metabolism; Jul2014, Vol. 34 Issue 7, p1188-1196, 9p |
Subject Terms: |
SEROTONIN receptors, SEROTONIN antagonists, RADIOACTIVE substances, BRAIN imaging, POSITRON emission tomography, CLINICAL trials, HEALTH outcome assessment |
Abstract: |
[11C]Cimbi-36 was recently developed as a selective serotonin 2A (5-HT2A) receptor agonist radioligand for positron emission tomography (PET) brain imaging. Such an agonist PET radioligand may provide a novel, and more functional, measure of the serotonergic system and agonist binding is more likely than antagonist binding to reflect 5-HT levels in vivo. Here, we show data from a first-in-human clinical trial with [11C]Cimbi-36. In 29 healthy volunteers, we found high brain uptake and distribution according to 5-HT2A receptors with [11C]Cimbi-36 PET. The two-tissue compartment model using arterial input measurements provided the most optimal quantification of cerebral [11C]Cimbi-36 binding. Reference tissue modeling was feasible as it induced a negative but predictable bias in [11C]Cimbi-36 PET outcome measures. In five subjects, pretreatment with the 5-HT2A receptor antagonist ketanserin before a second PET scan significantly decreased [11C]Cimbi-36 binding in all cortical regions with no effects in cerebellum. These results confirm that [11C]Cimbi-36 binding is selective for 5-HT2A receptors in the cerebral cortex and that cerebellum is an appropriate reference tissue for quantification of 5-HT2A receptors in the human brain. Thus, we here describe [11C]Cimbi-36 as the first agonist PET radioligand to successfully image and quantify 5-HT2A receptors in the human brain. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Cerebral Blood Flow & Metabolism is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |